MeiraGTx Holdings plc revenue breakdown overview

MeiraGTx Holdings plc revenue for the last year amounted to 14.02 M USD, the most of which — 14.02 M USD — came from its highest performing source at the moment, Retinal Drugs and Gene Therapies, the year earlier bringing 15.92 M USD. The greatest contribution to the revenue figure was made by United Kingdom — last year it brought MeiraGTx Holdings plc 14.02 M USD, and the year before that — 15.92 M USD.